Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
NICE is currently appraising the clinical and cost-effectiveness of tirzepatide within its marketing authorisation for managing obesity or overweight with risk factors
Just give it a minute and the bubbles will dissipate
For a deeper comparison of treatment options, see our Semaglutide vs Tirzepatide guide How Do GLP-1 Medications Promote Weight Loss
The FDA-approved indications for these medications differ: Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) are approved for chronic weight management in adults with BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity
This is a great advancement that will help fight the growing epidemic of childhood obesity and its associated health risks
US$ 21.24
US$ 20.12
US$ 27.56
US$ 26.35
US$ 29.29
US$ 22.89
US$ 22.41
